The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma

1. Raab, M.S.
2. Thomas, S.K.
3. Ocio, E.M.
4. Guenther, A.
5. Goh, Y.-T.
6. Talpaz, M.
7. Hohmann, N.
8. Zhao, S.
9. Xiang, F.
10. Simon, C.
11. Vanasse, K.G.
12. Kumar, S.K.